Related references
Note: Only part of the references are listed.Contribution of Putative Efflux Pump Genes to Isoniazid Resistance in Clinical Isolates of Mycobacterium tuberculosis
Anshika Narang et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2017)
Profiling the Proteome of Mycobacterium tuberculosis during Dormancy and Reactivation
Vipin Gopinath et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates
Guilian Li et al.
PLOS ONE (2015)
An Altered Mycobacterium tuberculosis Metabolome Induced by katG Mutations Resulting in Isoniazid Resistance
Du Toit Loots
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Plasma Metabolomics in Human Pulmonary Tuberculosis Disease: A Pilot Study
Jennifer K. Frediani et al.
PLOS ONE (2014)
Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
Liliana Rodrigues et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A Novel Metabolite of Antituberculosis Therapy Demonstrates Host Activation of Isoniazid and Formation of the Isoniazid-NAD+ Adduct
Sebabrata Mahapatra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis
Pedro Eduardo Almeida da Silva et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Mycobacterium tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of Isoniazid
Feng Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Examining the basis of isoniazid tolerance in non replicating Mycobacterium tuberculosis using transcriptional profiling
Griselda Tudo et al.
FUTURE MEDICINAL CHEMISTRY (2010)
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
G. E. Louw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis
Petros C. Karakousis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Mechanisms of action of isoniazid
Graham S. Timmins et al.
MOLECULAR MICROBIOLOGY (2006)
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Catherine Vilcheze et al.
NATURE MEDICINE (2006)
Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis
Sebastien Gagneux et al.
PLOS PATHOGENS (2006)
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase:: Adduct affinity and drug resistance
R Rawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reduced afflinity for isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance
SW Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans
AS Pym et al.
INFECTION AND IMMUNITY (2002)
Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling
JC Betts et al.
MOLECULAR MICROBIOLOGY (2002)
Action mechanism of antitubercular isoniazid - Activation mycobacterium tuberculosis KatG, isolation, and characterization of InhA inhibitor
BF Lei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
